Kwality Pharmaceuticals Ltd receives Product Approval for Tamoxifen 20mg Tablet in South Africa

Kwality Pharmaceuticals Ltd. (KPL) is pleased to announce that it has successfully obtained product approval in South Africa (SAHPRA) for our prominent oncology oral solid dosage (OSD) product, Tamoxifen 20mg Tablet, through a site transfer process.

This approval is a significant achievement in expanding the availability of this critical therapeutic, which plays a vital role in the treatment of hormone receptor-positive breast cancer. It reflects our ongoing commitment to providing high-quality, accessible oncology treatments to patients in key markets.

This approval further strengthens our presence in the High Regulated and global oncology market.

Shares of Kwality Pharmaceuticals Ltd was last trading in BSE at Rs. 896.65 as compared to the previous close of Rs. 879.80. The total number of shares traded during the day was 8598 in over 324 trades.

The stock hit an intraday high of Rs. 897.00 and intraday low of 879.80. The net turnover during the day was Rs. 7648350.00.

Source : Equity Bulls

Keywords

KwalityPharmaceuticals INE552U01010 SAHPRA ProductApproval OSD Tamoxifen